FIGURE 1: Depicts an overview of the role of gut microbiota (GM) in prostate cancer in the gut-prostate axis, which regulates the abundance of GM in the prostate via two distinct processes. (A) Eubiosis: In eubiosis, the abundance of beneficial microbes in the prostate is modulated by GM-associated therapeutics, which aids in the prevention or inhibition of disease progression in prostate cancer.(B) Dysbiosis: Dysbiosis is caused by various associated risk factors that dysregulate the GM-associated mechanisms, increase the abundance of pathogenic microbes, and enhance the pathogenesis of prostate cancer.